Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Double-Blind, Placebo-Controlled Proof of Concept Study to Evaluate LB1148 for Return of Gastrointestinal Function, Decrease Post-Operative Ileus in Subjects Undergoing Elective Bowel Resection

NCT05056935 is registered in ClinicalTrials.gov with Newsoara Biopharma Co., Ltd. as lead sponsor.

NCT NCT05056935
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05056935 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Double-Blind, Placebo-Controlled Proof of Concept Study to Evaluate LB1148 for Return of Gastrointestinal Function, Decrease Post-Operative Ileus in Subjects Undergoing Elective Bowel Resection
Lead sponsor
Newsoara Biopharma Co., Ltd.
Phase
Phase 2
Overall status
Completed
Start date
July 9, 2019
Completion date
August 8, 2020
Enrollment
131 (actual)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

ileus